Edit |   |
---|---|
Antigenic Specificity | NGF, Human (Fasinumab biosimilar) |
Clone | Fasinumab |
Host Species | Recombinant |
Reactive Species | human |
Isotype | IgG4 kappa |
Format | purified |
Size | 1mg, 5mg |
Concentration | 1mg/ml |
Applications | n/a |
Reviews / Ratings | If you have used this antibody, please help fellow researchers by submitting reviews to pAbmAbs and antYbuddY. |
Description | Anti-Human NGF Recombinant Antibody (Fasinumab). Fasinumab is a human monoclonal antibody designed for the treatment of acute sciatic pain. This drug was developed in collaboration by Teva Pharmaceutical Industries and Regeneron Pharmaceuticals. |
Immunogen | n/a |
Other Names | Anti-NGF Recombinant Antibody, Research Grade Fasinumab, Anti-Human NGF Recombinant Antibody(Fasinumab), REGN475, SAR164877, Antibody Drug Analogues, Monoclonal Antibody, YR1279, Research Grade Biosimilars, Biosimilar Antibody |
Gene, Accession # | CAS: 1190239-42-9 |
Catalog # | YR1279 |
Price | please inquire |
Order / More Info | NGF, Human (Fasinumab biosimilar) Antibody from KMD BIOSCIENCE CO. LTD. |
Product Specific References | n/a |